Results demonstrated that the targets of SZJN prescription for treating VD treatment were mainly associated with neuroactive ligand-receptor interaction, calcium, cholinergic synapse, cardiac myocyte adrenergic signal transduction, adipocyte lipolysis regulatory, apoptosis, cAMP, salivary secretion, tumor necrosis factor, 5-hydroxy color Aminergic synaptic, neurotrophin and AMPK signaling pathways (Fig. 6). The gene discussed is TNF; the disease is sexually transmitted disease.